Top

Published in:

01-03-2010

Quality Initiatives in Head and Neck Cancer

Author: Amy Y. Chen

Published in: Current Oncology Reports | Issue 2/2010

Abstract

A growing national health care initiative is gathering momentum to improve the quality of care for all Americans. Efforts to establish, monitor, and reward quality care have therefore been extensive. The Institute of Medicine has established that a large proportion of individuals do not receive recommended cancer care for their stage of disease, and that quality of care metrics should be established to decrease inappropriate care (overuse, under use, or wrong use). The American Head and Neck Society has been instrumental in developing quality measures for two of the most common head and neck cancers and in promoting adherence to these measures to improve quality of care for all patients.

Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.

Institute of Medicine: Medicare: A Strategy for Quality Assurance, Vol. 1. Edited by Lohr KN. Washington, DC: National Academy Press; 1990.

Donabedian A: The Definition of Quality and Approaches in Assessment, Vol. 1. Ann Arbor, MI: Health Administration Press; 1980.

•• National Quality Forum: NQF-Endorsed Standards. Available at http://www.qualityforum.org/Measures_List.aspx. Accessed on December 13, 2009. This resource provides the most complete performance standards currently available.

Bernier J, Cooper JS, Pajak TF, et al.: Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005, 27:843–850.CrossRefPubMed

Karnofsky D, Burchenal J: The clinical evaluation of chemotherapeutic agents in cancer. In MacLeod C, ed. Evaluation of chemotherapeutic agendas. New York: Columbia University Press, 1949:191–205.

Bartlett EE, Grayson M, Barker R, et al.: The effects of physician communications skills on patient satisfaction; recall, and adherence. J Chronic Dis 1984, 37:755–764.CrossRefPubMed

Hsieh MO, Kagle JD: Understanding patient satisfaction and dissatisfaction with health care. Health Soc Work 1991, 16:281–290.PubMed

Deyo RA, Inui TS: Dropouts and broken appointments. A literature review and agenda for future research. Med Care 1980, 18:1146–1157.CrossRefPubMed

10.

Cleary PD, McNeil BJ: Patient satisfaction as an indicator of quality care. Inquiry 1988, 25:25–36.PubMed

11.

Davies AR, Ware JE Jr: Involving consumers in quality of care assessment. Health Aff (Millwood) 1988, 7:33–48.CrossRef

12.

Hayward RA, Bernard AM, Rosevear JS, et al.: An evaluation of generic screens for poor quality of hospital care on a general medicine service. Med Care 1993, 31:394–402.CrossRefPubMed

13.

Malin JL, Schneider EC, Epstein AM, et al.: Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol 2006, 24:626–634.CrossRefPubMed

14.

•• Blayney DW, McNiff K, Hanauer D, et al.: Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center. J Clin Oncol 2009, 27:3802–3807. This article provides a comprehensive evaluation of a practice measure at work.CrossRefPubMed

15.

American Medical Association: Physician Consortium for Performance Improvement Measures 2009. Available at http://www.ama-assn.org/ama/pub/physician-resources/clinical-practice-improvement/clinical-quality/physician-consortium-performance-improvement/pcpi-measures.shtml. Accessed on December 12, 2009.

16.

American Medical Association: Oncology—Physician Performance Measurement Set 2007 (Updated 2009). Available at http://www.ama-assn.org/ama1/pub/upload/mm/370/oncology-ms.pdf. Accessed on December 12, 2009.

17.

Weber RS. Improving the quality of head and neck cancer care. Arch Otolaryngol Head Neck Surg 2007, 133:1188–1192.CrossRefPubMed

18.

Chen AY, Schrag N, Hao Y, et al.: Changes in treatment of advanced laryngeal cancer 1985–2001. Otolaryngol Head Neck Surg 2006, 135:831–837.CrossRefPubMed

19.

Chen AY, Schrag N, Hao Y, et al.: Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 2007, 117:16–21.CrossRefPubMed

20.

Chen AY, Pavluck A, Halpern M, Ward E: Impact of treating facilities’ volume on survival for early-stage laryngeal cancer. Head Neck 2009, 31:1137–1143.CrossRefPubMed

21.

Chen AY, Halpern M: Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007, 133:1270–1276.CrossRefPubMed

22.

Roland PS, Smith TL, Schwartz SR, et al.: Clinical practice guideline: cerumen impaction. Otolaryngol Head Neck Surg 2008, 139:S1–S21.CrossRefPubMed

23.

Rosenfeld RM, Brown L, Cannon CR, et al.: Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg 2006, 134:S4–S23.CrossRefPubMed

24.

Schwartz SR, Cohen SM, Dailey SH, et al.: Clinical practice guidelines: Hoarseness (Dysphonia). Otolaryngol Head Neck Surg 2009, 141:S1–S31.CrossRefPubMed

25.

Bhattacharyya N, Baugh RF, Orvidas L, et al.: Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2008, 139:S47–S81.CrossRefPubMed

26.

Rosenfeld RM, Culpepper L, Doyle KJ, et al.: Clinical practice guideline: otitis media with effusion. Otolaryngol Head Neck Surg 2004, 130:S95–S118.CrossRefPubMed

27.

Rosenfeld RM, Andes D, Bhattacharyya N, et al.: Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007, 137:S1–S31.CrossRefPubMed

28.

•• National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers. Guidelines for Treatment of Cancer by Site. Available at http://nccn/.org. Accessed on December 13, 2009. This resource provides the most up-to-date information on the current management of head and neck cancer.

29.

Clark CH, Miles EA, Urbano MT, et al.: Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br J Radiol 2009, 82:585–594.CrossRefPubMed

30.

Rosenthal DI, Asper JA, Barker JL Jr, et al.: Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head Neck 2006, 28:967–973.CrossRefPubMed

31.

•• Chen AY: The development of quality care measures for oral cavity cancer. Arch Otolaryngol Head Neck Surg 2008, 134:672. This article provided the first introduction to quality measures in the head and neck.CrossRef

32.

Hewitt M, Simone J: Enhancing Data Systems to Improved Quality of Cancer Care. Washington, DC: National Academies Press; 2000.

Title: Quality Initiatives in Head and Neck Cancer
Author: Amy Y. Chen
Publication date: 01-03-2010
Publisher: Current Science Inc.
Published in: Current Oncology Reports / Issue 2/2010
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI: https://doi.org/10.1007/s11912-010-0083-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?

Nanotechnology in Head and Neck Cancer: The Race Is On

Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer

The Relationship Between Vitamin D and Breast Cancer Incidence and Natural History

Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer

RANK Ligand: Effects of Inhibition

Keynote webinar | Spotlight on antibody–drug conjugates in cancer